AMPH strategy targets BAQSIMI and pipeline launches through 2026
AMPH management outlined a branded and complex generics strategy, citing BAQSIMI and new pipeline launches for mid to high single-digit revenue growth through 2026. Operational improvements and targeted R&D investments are expected to support margin expansion.